Dr Tian Wang is a Postdoctoral Research Fellow at The George Institute for Global Health and an Accredited Practising Dietitian. Her research spans cardiovascular disease, hypertension management, nutrition, and implementation science. Through a multidisciplinary approach, she works to improve cardiometabolic outcomes using both pharmaceutical (e.g., single-pill combination therapy) and non-pharmaceutical strategies (e.g., nutrition interventions).

Dr Wang currently leads the national evaluation of Australia’s 60-day dispensing policy for antihypertensive medicines and the post-hoc analysis of the GMRx2 international trials, which examine the effects of different antihypertensives on blood pressure variability—a novel marker of cardiovascular risk.

Her work has been published in leading journals, including the European Heart Journal and JAMA Network Open, generating over 340 citations in under 4.5 years of research. She has secured over $190,000 in research funding and presented at 14 national and international conferences, earning multiple awards, including being named a prize finalist at the 2025 Cardiac Society of Australia and New Zealand Conference.

In addition to her research, Dr Wang contributes to teaching, curriculum development, and supervision at UNSW and the University of Sydney. She is committed to equity, capacity building, and leadership development for early-career researchers, and currently serves on national committees including Hypertension Australia’s EMCR Committee and the Nutrition Society of Australia working group.